Intraductal endoscopic radiofrequency ablation for the treatment of hilar non-resectable malignant bile duct obstruction

doi:10.4253/wjge.v6.i1.13

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 6, Issue 1

This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6764)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-5) series, Tables (1-2) series.

Item

Count

PDF

434

HTML

3872

Figures (1-5)

165

Tables (1-2)

179

Sum=4650

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1093

Download

1021

Sum=2114

Jan 16, 2014 (publication date) through Apr 25, 2024

Times Cited of This Article

Times Cited (90)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Endoscopy

ISSN

1948-5190

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Article

World J Gastrointest Endosc. Jan 16, 2014; 6(1): 13-19
Published online Jan 16, 2014. doi: 10.4253/wjge.v6.i1.13

Full Size Figure Download Figure

Figure 4 Application of endoscopically guided, intraductal radiofrequency ablation in a 72-year-old patient with an extended perihilar cholangiocarcinoma (Klatskin tumor, stage Bismuth IV, histologically proven) involving all subsegments. Multisegmental radiofrequency ablation (RFA) applications were performed (from left above to lower right). The patient experienced no treatment-associated complications and was doing well 15 mo after the initiation of endoscopic RFA treatment.

Citation: Tal AO, Vermehren J, Friedrich-Rust M, Bojunga J, Sarrazin C, Zeuzem S, Trojan J, Albert JG. Intraductal endoscopic radiofrequency ablation for the treatment of hilar non-resectable malignant bile duct obstruction. World J Gastrointest Endosc 2014; 6(1): 13-19
URL: https://www.wjgnet.com/1948-5190/full/v6/i1/13.htm
DOI: https://dx.doi.org/10.4253/wjge.v6.i1.13